Keytruda wins approval as combination therapy for kidney cancer
The drug was approved in combination with Pfizer’s Inlyta to treat advanced renal cell carcinoma. Read More
6 years ago
The drug was approved in combination with Pfizer’s Inlyta to treat advanced renal cell carcinoma. Read More